AAAAAA

   
Results: 1-3 |
Results: 3
Antithrombotic efficacy of thrombin inhibitor L-374,087: Intravenous activity in a primate model of venous thrombus extension and oral activity in a canine model of primary venous and coronary artery thrombosis
Authors: Cook, JJ Gardell, SJ Holahan, MA Sitko, GR Stump, GL Wallace, AA Gilberto, DB Hare, TR Krueger, JA Dyer, DL Sanderson, PEJ Vacca, JP Shafer, JA Lynch, JJ
Citation: Jj. Cook et al., Antithrombotic efficacy of thrombin inhibitor L-374,087: Intravenous activity in a primate model of venous thrombus extension and oral activity in a canine model of primary venous and coronary artery thrombosis, J PHARM EXP, 289(1), 1999, pp. 503-510
Non-peptide GPIIb/IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregation. (vol 42, pg 2409, 1999)
Authors: Egbertson, MS Cook, JJ Bednar, B Prugh, JD Bednar, RA Gaul, SL Gould, RJ Hartman, GD Homnick, CF Holahan, MA Libby, LA Lynch, JJ Lynch, RJ Sitko, GR Stranieri, MT Vasallo, LM
Citation: Ms. Egbertson et al., Non-peptide GPIIb/IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregation. (vol 42, pg 2409, 1999), J MED CHEM, 42(19), 1999, pp. 4014-4014
Non-peptide GPIIb IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregation
Authors: Egbertson, MS Cook, JJ Bednar, B Prugh, JD Bednar, RA Gaul, SL Gould, RJ Hartman, GD Homnick, CF Holahan, MA Libby, LA Lynch, JJ Lynch, RJ Sitko, GR Stranieri, MT Vassallo, LM
Citation: Ms. Egbertson et al., Non-peptide GPIIb IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregation, J MED CHEM, 42(13), 1999, pp. 2409-2421
Risultati: 1-3 |